JonathanDissinMD

PubMed

• 6 citations
  Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic Stroke.
  Brian Mac Grory, DaJuanicia N Holmes, Roland A Matsouaka, Shreyansh Shah, Cherylee W J Chang
  JAMA. 2023-06-20
• 7 citations
  Predictive Value of the Bispectral Index for Burst Suppression on Diagnostic Electroencephalogram During Drug-Induced Coma
  Richard Arbour, Jonathan Dissin
  The Journal of Neuroscience Nursing. 2015-04-01
• 3 citations
  Proteinuria Predicts Resistance to Antiplatelet Therapy in Ischemic Stroke
  Gemlyn George, Nikul K. Patel, Cecilia Jang, David S. Wheeler, Sridhara Yaddanapudi
  Translational Stroke Research. 2018-04-01

Journal Articles

• Prabhu AM, Raghupathi R, Dissin J.  
  Myriad manifestations of a global infectious disease, Neurol.86:e234-e238,, 6/6/2016
• Arbour RB, Dissin J.  
  Predictive value of the bispectral index for burst suppression on diagnostic EEG during drug induced coma, J. Neurosci Nurs 47:113-122, 4/2015
• Effect of aspirin and warfarin therapy in stroke patients with valvular strand.  
  Homma S, Di Tullio MR, Sciacca RR, Sacco RL, Mohr JP: PICSS Investigators, Stroke
• The WARSS/APASS Collaborative Study: Baseline aPL Prevalence. 9th International Symposium on Antiphospholipid Antibody, Tours, Loire Valley, France.  
  Levine SR, Brey RL, Tilley BC, Thompson JLP, Sacco RL, Xu D, Costigan TM, Triplett DA, Mohr JP, and the WARSS/APSS Collaborative Study Investigators, J Autoimmunity
• The WARSS/APASS Collaborative Study: A prospective, multicenter study of the significance of anti-phospholipid antibodies in a large, ischemic stroke cohort.  
  Levine SR, Brey RL, Tilley BC, Thompson JLP, Sacco RL, Triplett DA, Costigan T, Mohr JP, and the WARSS/APSS Collaborative Study Investigators, J Autoimmunity, Supplement
• Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm.  
  Homma S, Thompson JLP, Pullicino P et al. for the WARCEF Investigators, N Eng J Med
• NXY-059 for acute ischaemic stroke: Results of the SAINT II trail.  
  Shuaib A, Lees K, Lyden P, Grotta J, Davalos A, Davis J, Diener HC, Ashwood T, Wasiewski W, Emeribe U, for the SAINT II Investigators, N Engl J Med
• Glatiramer acetate in treatment- Naive and prior interferon-B-1b-treated multiple sclerosis patients.  
  Zwibel HL for the Copolymer-1 Treatment Study Principal Investigators, Acta Neurol Scand
• Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rational, objectives and design.  
  Pullicino P, Thompson JLP, Barton B, Levin B, Graham S, Freudenberger RS, WARCEF Investigators, J Cardiac Fail
• The Association of Outcome with Early Stroke Treatment: pooled analysis of Atlantis, ECASS, and NINDS rt-PA stroke trials.  
  The Atlantis, ECASS, and NINDS rt-PA Study Group Investigators, Lancet
• The Role of Antiphospholipid Antibodies in Predicting Subsequent Thrombo-Occlusive Events.  
  The Antiphospho- Lipid Antibodies and Stroke Study (APASS) The APASS Investigators, JAMA
• Experimental Induction of Pancreatic Adenocarcinoma.  
  Dissin J, Mills LR, Mains DL, Black O, Webster PD, J Nat. Cancer Inst
• Aspirin and Ticlopidine for the prevention of recurrent stroke in black patients: a randomized trial.  
  Gorelick PB, Richardson D, Kelly M, Ruland S, Hung E, Harris Y, Kittner S, Leuergans S: African American Antiplatelet Stroke Prevention Study Investigators, JAMA
• Comparison of Warfarin and Aspirin in the Prevention of Recurrent Ischemic Stroke.  
  Mohr J. P. et. al, N. Eng J Med
• Intravenous Tissue-Type Activator for Treatment Of Acute Stroke.  
  Albers GW, Bates VE, Clark WM, Bell R, et al, J.A.M.A
• Prehospital and Emergency Department Delays After Acute Stroke.  
  Morris Dl, Rosamond W, Madden K, et al, Stroke
• Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset.  
  Clark W, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S, for the ATLANTIS Study Investigators, The ATLANTIS Study: A Randomized Controlled Trial JAMA
• Effect of low-intensity anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation.  
  Kistler JP, Singer DE, Millenson MM, Bauer KA, Gress DR, Barzegar S, Hughes RA, Sheehan M, Maraventano SW, and Oertel LB, Stroke
• The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: the BAATAF study.  
  Singer DE, Hughes RA, Gress DG, Sheen MA, Oertel LB, Maraventano SW, Blewett DR, Rosner B, Kistler JP, for the BAATAF Investigators, Am Heart J
• Compartmentalizing Oxidative Stress.  
  Newman GC, Dissin J, Futur. Lipidol
• Triptan Induced Use Preceding Life Threatening Arrhythmias in Charcot-Marie-Tooth: A Case Report and Review of the Literature.  
  Rubinstein J, Moghe R, Mizrachi A, Dissin J, J. Clin Neuropharm
• Join now to see all

Abstracts/Posters

• Sandulescu MC, Roby D, Multani S, Dissin J.
  Subacute bulbar failure with blown pupils due to wound botulism, American Neurologic Assoc. 138th meeting, New Orleans, LA, 10/13/2013
• Predictive Value of the Bispectral Index (BIS) for Burst Suppression on Diagnostic EEG in Drug –induced Coma.
  Arbour R, Dissin J, AACN National Institute and Critical Care Exposition, Boston, MA, 5/20/2013
• Collaborative Practice and Implementation of a Therapeutic Hypothermia Protocol in a Tertiary Care Referral Center.
  Arbour R, Strain J, Dissin J, Wani A, Witzke C, Wechter K, Kilmer K, Weber ME, Benjamin-Mylnarczuk S, AACN National Institute and Critical Care Exposition, Boston, MA, 5/20/2013
• Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.
  Homma S, Sacco RL, et al. PFO in Cryptogenic Stroke Study (PICSS) Investigators, Circulation
• Stroke in the WARCEF Trial.
  Pullicino P, Thompson JLP, Sacco R, Sanford AR, Qian M, Mohr JP, Homma S, for the WARCEF Investigators, International Stroke Conference, Honolulu, HI
• Analysis of Warfarin or Aspirin Benefit in Subgroups in WARCEF.
  Homma S, Thompson JLP, for the WARCEF Investigators, Heart Failure Society of America meeting, Seattle, WA
• The Results of the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF).
  Homma S, Thompson JLP, for the WARCEF Investigators, Trial International Stroke Conference
• Frontal Lobotomy: An Outdated Diagnosis?
  Sattenberg RJ, Garfinkle W, Dissin J, Shrivasta A, Guttentag AR, ASNR 44th Annual Meeting, San Diego, CA
• Relationship of PFO with Cryptogenic Stroke.
  Homma S, Sacco RL, et al, American Heart Assoc. Meeting, Anaheim, CA
• Relationship of Atrial Septal Aneurysm with Patent Foramen Oval.
  Homma S, Sacco, RL et al, American Heart Assoc. Meeting, Anaheim, CA
• A Case of Systemic Lupus Erythematosus with Cortical Blindness.
  Pandya, D.P. and Dissin, J, Southern Medical Journal
• Antiphospho- Lipid Antibody Portfolio Predicts a High-Risk Subgroup of Ischemic Stroke Patients for Subsequent Events: Preliminary APASS-WARSS Results.
  Levine SR, Brey RL, Tilley BC, Lin Y, Thompson JLP, Sacco RL, Mohr JP, and the APASS Investigators, International Stroke Conference
• NXY-059 for the Treatment of Acute Stroke. Pooled Analysis of the SAINT I and SAINT II Trails.
  Diener HC, Lees K, Lyden P, Grotta J, Davalos A, Davis S, Shuaib A, Ashwood T, Wasiewski W, Aldefer V, Hardemark HG, Rodichok L; for the SAINT I and II Investigators, Stroke
• Siblings With Ischemic Stroke Study. Results of a Genome-Wide Scan for Stroke Loci.
  Meschia JF, Nalls M, Martarin M, Brott TG, Brown RD, Hardy J, Rich SS, Singleton A, Hernandez D, Ferrucci L, Pearce K, Keller M, Worral RB for the Siblings With Ischem..., Stroke
• The WARSS/APASS collaboration: Management and statistical issues in a multi-study clinical trial involving anti-phospholipid antibodies.
  Thompson JLP, Brey RL, Tilley BC, Sacco RL, Levin B, Mohr JP, Levine SR, Lupus
• Baseline frequencies, isotypes, and titers of anti-phospholipid antibodies in the Warfarin Aspirin Recurrent Stroke Study/Anti-phospholipid Antibody in Stroke Study (W...
  Brey RL, Levine SR, Thompson JLT, Sacco RL, Tilley BC, Costigan TM, Rhine CB, Zidel A, Ruzicka J, Xu D, Mohr JP, APASS/WARSS Collaborative Study Investigators, Stroke
• Join now to see all